-
Mashup Score: 1Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews - 2 year(s) ago
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to have benefit in patients with heart failure (HF). Multiple systematic reviews and meta-analyses (SRs and MAs) of randomized control trials (RCTs) comparing SGLT2i to placebo have been performed. However, there is uncertainty in the quality of the evidence and associated efficacy. We performed an overview of SRs and MAs of RCTs…
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management - 2 year(s) ago
Syncopal events in patients with hypertrophic cardiomyopathy (HCM) are of concern as they are a vital consideration in algorithms for risk stratification for sudden cardiac death (SCD) and ICD implantation. However, the cause of syncope is often under-investigated and/or unexplained. Current syncope guidelines do not provide a detailed definition of unexplained syncope.To address this important…
Categories: Cardiologists, Latest HeadlinesTweet-
https://t.co/1JQSMLXZLc
-
-
Mashup Score: 0Global strain in moderate aortic valve stenosis with reduced left ventricular ejection fraction: A piece of the puzzle - 2 year(s) ago
Surgical (SAVR) or transcatheter (TAVR) aortic valve replacement (AVR) is recommended for severe aortic stenosis in patients with symptoms attributable to the valve disease or left ventricular ejection fraction (LVEF) <50% [1]. AVR is currently not considered until the stenosis becomes severe, unless there are concomitant indications for cardiac surgery [1]. However, it is increasingly recognised...
Categories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/UjQEaYAmS6
-
-
Mashup Score: 0
An evidence-based approach for risk stratification of subclinical atrial fibrillation (AF) and hereby AF screening is lacking. This study aimed to investigate whether established cardiovascular diseases (CVD) could help to identify the population more likely to benefit from AF screening.
Categories: Cardiologists, Latest HeadlinesTweet-
For individuals aged >=70 years, screening for #AFib with an ILR didn’t prevent #stroke in those with CVD, but was associated with ~40% stroke risk reduction in those without CVD 🤔, older people with CVD are more likely to have non-cardioembolic stroke https://t.co/6bntCwxdIv
-
-
Mashup Score: 95Avoiding bias in measuring “hemisphere radius” in echocardiographic mitral regurgitation quantification: Mona Lisa PISA - 2 year(s) ago
The conventional “Proximal Isovelocity Surface Area” (PISA) technique is the standard clinical method to quantify the effective regurgitant orifice area (EROA) in mitral regurgitation (MR) [1–4]. Using conventional PISA, the operator must measure the distance r (“radius”) between the flow convergence zone and the orifice. Traditionally the teaching is that the radius should be measured…
Categories: Cardiologists, Latest HeadlinesTweet-
RT @hahn_rt: Improving the Accuracy of PISA for regurgitation quantitation. https://t.co/yGCVcFy82e. #EchoFirst @Cardionerds @ASE360 @iamr…
-
-
Mashup Score: 3Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews - 2 year(s) ago
Sodium-Glucose transporter 2 inhibitors (SGLT2i) have been shown to have benefit in patients with heart failure (HF). Multiple systematic reviews and meta-analyses (SR and MA) of randomized control trials (RCTs) comparing SGLT2i to placebo have been performed. However, there is uncertainty in the quality of the evidence and associated efficacy. We performed an overview of SR and MA of RCTs to…
Categories: Cardiologists, Latest HeadlinesTweet-
According to a recent umbrella review, 'SGLT2i are possibly beneficial in patients with HF, however, none of the SRs and MA compared the efficacy between different types of SGLT2i' https://t.co/WuBUE9Tbr2 https://t.co/S1FAM3sij9
-
-
Mashup Score: 2Sex differences in patients with acute coronary syndromes and non-obstructive coronary arteries: Presentation and outcome - 2 year(s) ago
A substantial number of patients present with a suspected ACS and non-obstructive coronary arteries; sex differences in these patients are not well understood.This study aims to evaluate the impact of sex on clinical presentation and outcome in patients with suspected acute coronary syndrome (ACS) and non-obstructive coronary arteries with a final diagnosis confirmed by cardiovascular magnetic…
Categories: Cardiologists, Latest HeadlinesTweet-
RT @DeepDastidar: Sharing our latest work! Sex differences in patients with #MINOCA: Presentation and outcome https://t.co/mOZYGsNVSM @matt…
-
-
Mashup Score: 3
I want a fever, in poetry: a fever, and tranquillity.James Dickey
Categories: Cardiologists, Latest HeadlinesTweet-
A global view on the incidence and mortality of infective endocarditis, by Roever, Bhatt and Biondi-Zoccai https://t.co/UJshzvViX7 @DLBHATTMD https://t.co/o7womNkvZZ
-
-
Mashup Score: 1A contemporary risk model for predicting 30-day mortality following percutaneous coronary intervention in England and Wales - 2 year(s) ago
The current risk model for percutaneous coronary intervention (PCI) in the UK is based on outcomes of patients treated in a different era of interventional cardiology. This study aimed to create a new model, based on a contemporary cohort of PCI treated patients, which would: predict 30day mortality; provide good discrimination; and be well calibrated across a broad risk-spectrum.
Categories: Cardiologists, Latest HeadlinesTweet-
@agtruesdell @LAzzaliniMD @Ravi_Hira_MD @NosairMohamed @aspergian1 @rwyeh @ajaykirtane @ziadalinyc @KateKearney4 @ArasiMaran @RhianEDavies1 @djc795 They published this before we released the @BCIS_uk risk score that ee use for national reporting https://t.co/YB6eQxkUwF this score is well calibrated even at higher risk https://t.co/IAcFYsEAy0
-
-
Mashup Score: 23The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism - 2 year(s) ago
To evaluate the clinical care provided to cancer patients hospitalized for acute pulmonary embolism (PE), as well as the association between type of cancer, in-hospital care, and clinical outcomes.
Categories: Cardiologists, Latest HeadlinesTweet-
1. Analysis led by @Aaron_S_Mai around treatment of PE and outcomes in patients with cancer with @onco_cardiology @islamelgendy83 @sunlouise1 @RodrigoBagur @hvanspall ➡️ https://t.co/oOw0Ub61ik Cancer highly prevalent among patients hospitalized for PE. @alaide_chief @Hragy https://t.co/58No719Ez8
-
According to a recent umbrella review on SGLT2i in HF, 'most of the SRs and MAs showed benefits in mortality, HF hospitalizations, and KCCQ score change... However, none of SRs and MAs compared efficacy between different types of SGLT2i' https://t.co/WuBUEaaMPC https://t.co/UdZTm9xXkC